List of Ozobax drug patents

Ozobax is owned by Metacel Pharms Llc.

Ozobax contains Baclofen.

Ozobax has a total of 1 drug patent out of which 0 drug patents have expired.

Ozobax was authorised for market use on 18 September, 2019.

Ozobax is available in solution;oral dosage forms.

Ozobax can be used as treatment of spasticity.

The generics of Ozobax are possible to be released after 30 August, 2039.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10610502 METACEL PHARMS LLC Oral baclofen solutions
Aug, 2039

(16 years from now)

Drugs and Companies using BACLOFEN ingredient

Market Authorisation Date: 18 September, 2019

Treatment: Treatment of spasticity

Dosage: SOLUTION;ORAL

How can I launch a generic of OZOBAX before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in